Wanbury Limited (NSE:WANBURY)

Market Cap	9.62B
Revenue (ttm)	6.00B
Net Income (ttm)	305.30M
Shares Out	n/a
EPS (ttm)	8.98
PE Ratio	31.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,721
Average Volume	218,118
Open	299.35
Previous Close	295.10
Day's Range	292.30 - 305.00
52-Week Range	142.20 - 329.70
Beta	0.34
RSI	60.23
Earnings Date	May 16, 2025

About Wanbury

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 1,491
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: WANBURY

Financial Performance

In 2024, Wanbury's revenue was 6.00 billion, an increase of 4.15% compared to the previous year's 5.76 billion. Earnings were 305.30 million, a decrease of -45.44%.